MSII - Onley

MSII leverages an innovative and patented approach, Physiologic Insulin Resensitization™, where insulin is administered as a hormone rather than a conventional drug. This groundbreaking technique directly addresses the root cause of Diabetes—metabolic failure. By mimicking normal physiology, this modality aims to reduce insulin resistance, enabling blood sugar to enter cells more efficiently for energy conversion. The use of insulin as a hormone communicator aligns with the body's natural maintenance of optimized metabolism, distinguishing our approach from the traditional use of insulin as a symptom-suppressing drug. This physiologically identical method contributes to the reduction of insulin resistance, fostering a more natural and effective response.